Albireo Pharma Inc (ALBO)
Market Closed
2 Mar, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
44. 15
0
0%
$
915.89M Market Cap
- P/E Ratio
- Div Yield
1.24M Volume
- Eps
$ 44.15
Previous Close Investors:
Want to track ALBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Albireo Pharma Inc (ALBO) Statistics
Valuation metrics
Market Cap 915.89M
Enterprise value 677.78M
Trailing P/E (ttm) -5.61
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 22.57
Price/Book (mrq) 4.83
Enterprise Value/Revenue 16.7
Enterprise Value/EBITDA -34.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 16.02
52-Week high 45.23
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 4 Nov 2016
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.73%
Operating margin -3.04%
Operational effectiveness
Return on assets -0.5%
Return on equity -0.85%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.91
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 5.93%
Book value per share (mrq) 9.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
